U.S. Markets closed
  • S&P Futures

    4,134.50
    -12.25 (-0.30%)
     
  • Dow Futures

    32,683.00
    -74.00 (-0.23%)
     
  • Nasdaq Futures

    13,188.25
    -40.50 (-0.31%)
     
  • Russell 2000 Futures

    1,916.30
    -5.50 (-0.29%)
     
  • Crude Oil

    88.57
    -0.44 (-0.49%)
     
  • Gold

    1,790.20
    -1.00 (-0.06%)
     
  • Silver

    19.80
    -0.05 (-0.24%)
     
  • EUR/USD

    1.0176
    -0.0011 (-0.1119%)
     
  • 10-Yr Bond

    2.8400
    +0.1640 (+6.13%)
     
  • Vix

    21.15
    -0.29 (-1.35%)
     
  • GBP/USD

    1.2071
    +0.0001 (+0.0072%)
     
  • USD/JPY

    135.1510
    +0.1810 (+0.1341%)
     
  • BTC-USD

    23,193.81
    +275.15 (+1.20%)
     
  • CMC Crypto 200

    539.51
    +4.28 (+0.80%)
     
  • FTSE 100

    7,439.74
    -8.32 (-0.11%)
     
  • Nikkei 225

    28,130.26
    -45.61 (-0.16%)
     

Neptune Wellness Looks To Co-Develop CBD Products With International Flavors & Fragrances

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) announced Wednesday it's pursuing a partnership with International Flavors & Fragrances Inc. (NYSE: IFF) to co-develop hemp-derived CBD products.

Neptune Wellness Solutions is a company that extracts, purifies and formulate health and wellness products. Its wholly-owned subsidiary 9354-7537 Québec Inc. possesses a Health Canada license for processing cannabis.

See Also: Canopy Growth Enters Sports Nutrition Space, Acquires Majority Stake in BioSteel Sports Nutrition

"IFF is a well-recognized leader and innovator in taste, scent, nutrition and ingredients and we could not be more excited at the potential of combining the resources of our two organizations to develop plant-based consumer products, including hemp-derived CBD products,” said Michael Cammarata, CEO of Neptune.

“The formulation and technological expertise that IFF cumulates will greatly benefit Neptune in accelerating its market penetration in the U.S. CBD market. This partnership aligns well with our growth strategy of expanding core customers and of supporting consumer packaged goods companies and fragrance houses' expansion into the CBD market."

Neptune’s stock traded higher by 8.9% to $3.90 per share in Wednesday's pre-market session.

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.